| 名称 |
品牌 |
货号 |
规格 |
价格 |
|---|
10-oxo-12(Z)-Octadecenoic Acid |
Cayman |
36977-100µg |
100 µg |
1,489.601,568.00
|
10-oxo-12(Z)-Octadecenoic Acid |
Cayman |
36977-1mg |
1 mg |
8,139.608,568.00
|
10-oxo-12(Z),15(Z)-Octadecadienoic Acid |
Cayman |
36976-50µg |
50 µg |
2,340.802,464.00
|
10-oxo-12(Z),15(Z)-Octadecadienoic Acid |
Cayman |
36976-25µg |
25 µg |
1,236.901,302.00
|
10-oxo-12(Z),15(Z)-Octadecadienoic Acid |
Cayman |
36976-100µg |
100 µg |
4,415.604,648.00
|
LipidLaunch™ LNP-MC3 Exploration Kit |
Cayman |
36970-1ea |
1 ea |
3,511.203,696.00
|
Abl Substrate Peptide (trifluoroacetate salt) |
Cayman |
36969-5mg |
5 mg |
3,577.703,766.00
|
Abl Substrate Peptide (trifluoroacetate salt) |
Cayman |
36969-25mg |
25 mg |
11,451.3012,054.00
|
Abl Substrate Peptide (trifluoroacetate salt) |
Cayman |
36969-10mg |
10 mg |
6,104.706,426.00
|
Abl Substrate Peptide (trifluoroacetate salt) |
Cayman |
36969-1mg |
1 mg |
1,024.101,078.00
|
Glucose-dependent Insulinotropic Peptide (22-51) (human) (tr |
Cayman |
36968-5mg |
5 mg |
1,622.601,708.00
|
Glucose-dependent Insulinotropic Peptide (22-51) (human) (tr |
Cayman |
36968-25mg |
25 mg |
7,208.607,588.00
|
Glucose-dependent Insulinotropic Peptide (22-51) (human) (tr |
Cayman |
36968-10mg |
10 mg |
3,059.003,220.00
|
Glucose-dependent Insulinotropic Peptide (22-51) (human) (tr |
Cayman |
36968-1mg |
1 mg |
345.80364.00
|
LIH383 (trifluoroacetate salt) |
Cayman |
36967-5mg |
5 mg |
3,178.703,346.00
|
LIH383 (trifluoroacetate salt) |
Cayman |
36967-25mg |
25 mg |
12,355.7013,006.00
|
LIH383 (trifluoroacetate salt) |
Cayman |
36967-10mg |
10 mg |
5,652.505,950.00
|
LIH383 (trifluoroacetate salt) |
Cayman |
36967-1mg |
1 mg |
718.20756.00
|
GluR2 (831-842) (human, mouse, rat) (trifluoroacetate salt) |
Cayman |
36966-5mg |
5 mg |
1,542.801,624.00
|
GluR2 (831-842) (human, mouse, rat) (trifluoroacetate salt) |
Cayman |
36966-25mg |
25 mg |
5,945.106,258.00
|